Dongyangguang pharmaceutical has accepted 13 varieties this year

According to the website of the State Food and Drug Administration (CFDA) on April 16, the six kinds of generic chemical drugs applied for production by Guangdong dongyangguang Pharmaceutical Co., Ltd were accepted, becoming the 13th variety accepted by the company this year The new drugs intensively declared by dongyangguang Pharmaceutical Co., Ltd this year are involved in many treatment fields, including 9 indications, including respiratory tract infection, irritant dry cough, type 2 diabetes, primary Parkinson's disease, high cholesterol, tumor, influenza, unstable angina pectoris and schizophrenia, of which anti infective drugs are the main ones In terms of application types, it includes 2 new drugs of category 1.1 (drugs not marketed at home and abroad), 1 new drug of category 3.1 (drugs already marketed at abroad but not yet marketed at home), 1 new drug of category 5 (changing the dosage forms of drugs already marketed at home), and 9 generic drugs of category 6 (products with national drug standards) Guangdong dongyangguang Pharmaceutical Co., Ltd is the holding subsidiary of Yichang dongyangguang Pharmaceutical Co., Ltd and one of the enterprises authorized by Roche Group of Switzerland to produce h7n9 avian influenza drug oseltamivir phosphate (Tamiflu) At present, Guangdong dongyangguang pharmaceutical has little impact on the performance of dongyangguang aluminum.